MD Magazine: Specialty: Ophthalmology Copyright (c) 2017 Intellisphere, LLC. All rights reserved. Ophthalmology en-us Wed, 23 Aug 2017 04:08:12 UTC Aflibercept Aids Visual Acuity in PROMISE Study Tue, 15 Aug 2017 23:06:00 UTC Unapproved Stem Cell Therapies Are Causing "Dismal" Health Outcomes Tue, 15 Aug 2017 22:22:00 UTC Fewer Ranibizumab Doses OK for mCNV Tue, 15 Aug 2017 22:02:00 UTC Aflibercept Delivers Dynamic Vascular Changes in DME, RVO Tue, 15 Aug 2017 18:06:00 UTC Novel Device Could Represent New Endpoint in Clinical Trials for Visual Function Mon, 14 Aug 2017 19:54:00 UTC Sirolimus/Aflibercept Combo Shows Potential Benefits for Wet AMD Mon, 14 Aug 2017 19:23:00 UTC OPT-302 Meets Phase 1/2A Endpoints as Pan-VEGF Inhibitor for nAMD Mon, 14 Aug 2017 18:13:00 UTC Aflibercept Similar to Ranibizumab in Visual Acuity Improvements in VIEW Studies Mon, 14 Aug 2017 16:23:00 UTC ICON-1 Plus Ranibizumab Shows Promise for Wet AMD Mon, 14 Aug 2017 16:05:00 UTC Intravitreal Sirolimus Lowers Vitreous Haze Scores, Tapers Corticosteroid Use in SAKURA Study Sun, 13 Aug 2017 18:58:00 UTC Bevacizumab Could Prevent Retina Re-Detachment After PPV Sun, 13 Aug 2017 17:15:00 UTC Adalimumab Superior to Placebo Across Uveitis Idiopathic Etiologies Sun, 13 Aug 2017 15:52:00 UTC Real-World Anti-VEGF DME Data Differ from Randomized Results Sun, 13 Aug 2017 15:50:00 UTC C3F8 Superior to SF6 and Air in Treatment of Vitreomacular Traction Sat, 12 Aug 2017 18:31:00 UTC Severe Diabetic Retinopathy Leads to Higher Rate of Visual-Function Issues Fri, 28 Jul 2017 09:00:00 UTC AMD Diagnoses Aided By Deep Learning Programs Tue, 25 Jul 2017 15:42:00 UTC AbbVie's HUMIRA Gets Positive Outlook from EMA Fri, 21 Jul 2017 14:41:00 UTC FDA Accepts Application for Potential First Gene Therapy for Genetic Disease in US Mon, 17 Jul 2017 17:25:00 UTC Biomarkers for Inflammation May Help Identify Risk for AMD Mon, 17 Jul 2017 16:40:00 UTC In Treatment-Resistant AMD, Contrast Sensitivity Improved after Switch from Ranibizumab to Aflibercept Thu, 13 Jul 2017 13:00:41 UTC Oral Drug X-82 Shows Promise for Wet Age-Related Macular Degeneration Mon, 10 Jul 2017 19:45:54 UTC Brolucizumab Meets Endpoints in Phase III Trials Tue, 20 Jun 2017 13:58:50 UTC FDA Approves Allergic Conjunctivitis Treatment Zerviate Wed, 31 May 2017 01:55:00 UTC Study Finds 25% of Patients with AMD Remain Undiagnosed After Dilated Eye Exam Tue, 23 May 2017 07:17:00 UTC At-Risk Drivers Can Be Identified by Visual, Cognitive Acuity Fri, 12 May 2017 07:42:00 UTC Seeing into the Future Collaborative Care to Maintain Eye Health in Patients with Diabetes /seeing-into-the-future-collaborative-care-to-maintain-eye-health-in-patients-with-diabetes Fri, 12 May 2017 06:21:00 UTC New Baseline Models of DR Prediction Emerge at ARVO Thu, 11 May 2017 07:46:00 UTC Study: Eating Fish Protects Against Diabetic Retinopathy in Asians Thu, 11 May 2017 05:22:00 UTC Many With Diabetic Retinopathy Going Unscreened, Undiagnosed Wed, 10 May 2017 08:49:00 UTC Aflibercept Vs. Ranibizumab: Similar QOL Benefits, Varied Costs for Treating Diabetic Macular Edema Wed, 10 May 2017 07:08:00 UTC